Corsair Gaming is the latest meme stock as Reddit forum Wallstreetbets calls it the next millionaire stock maker.
Chipmaker AMD reports earnings for the Q2 driving by strong revenue growth year over year.
Peter Hanks, an anlyst at DailyFX, analyzes what Microsoft's earnings beat means for the future of the stock.
Shares of Chinese electric-vehicle (EV) maker Nio (NYSE: NIO) are about 30% below January 2021 highs. Nio ES8 electric SUVs being loaded for transit to Norway. Nio has been quickly growing sales of its EVs.
Shares of Novavax (NASDAQ: NVAX) were sliding 6.7% lower as of 11:14 a.m. EDT on Tuesday. The decline came after the Australian newspaper The Guardian reported major delays with Australia's supply deal for Novavax's COVID-19 vaccine, NVX-CoV2373. Novavax signed an agreement in January 2021 to supply 51 million doses of its COVID vaccine to Australia.
As talk of potential legislation to legalize cannabis in the U.S. continues, stocks of many Canadian growers have been volatile. In just the past month, shares of Tilray (NASDAQ: TLRY), Sundial Growers (NASDAQ: SNDL), and OrganiGram Holdings (NASDAQ: OGI) are down 30%, 20%, and 18%, respectively. Tilray CEO Irwin Simon did give an interview yesterday in which he discussed the future of the company and explained its position in preparation for potential U.S. legalization.
(Bloomberg) -- Another double-digit share price rally could be in store for Cassava Sciences Inc. over the next month, as the biotech vies with retail trading favorites AMC Entertainment Holdings Inc. and GameStop Corp. to be the year’s top-performing stock in the Russell 3000.In the run-up to the big reveal from a mid-stage study, the 23-year old drug developer has sprinted more than 1,700% this year. On July 29, Cassava is expected to present safety and cognition data from about 50 people with
TDOC earnings call for the period ending June 30, 2021.
Infinity Pharmaceuticals Inc (NASDAQ: INFI) has issued data updates from two mid-stage trials for eganelisib, its oral immuno-oncology candidate. Data: 49 patients were enrolled in the MARIO-275 study designed to evaluate it as a combination therapy with Bristol-Myers Squibb Co's (NYSE: BMY) Opdivo (nivolumab) in platinum-refractory, I/O naïve patients with advanced urothelial cancer. In the combination arm, the median overall survival (mOS) in the intent to treat (ITT) population stood at 15.4
Teladoc's shares had already shed a quarter of their value from the start of the year on concerns over how virtual health firms would fare as the economy reopened.
(Bloomberg) -- QuantumScape Corp., the electric-vehicle battery company that went public last fall, said Tuesday it has advanced to testing 10-layer cells, a sign it’s on track in efforts to develop a commercially viable solid-state battery.QuantumScape, which counts Volkswagen AG as its biggest shareholder, is among a group of companies developing solid-state batteries, which could dramatically speed up EV adoption by providing a safer, cheaper alternative to current lithium-ion batteries. It h
Carnage in China's financial markets signals the beginning of a new era, investors say, as the government puts socialism before shareholders and regulatory changes rip apart the old playbook. Stocks and sentiment have taken a drubbing as Communist Party rulers seek to remake the property, technology and education sectors to curb cost pressures and better serve ordinary people. The new model appears to place common prosperity, as President Xi Jinping has put it, ahead of helter-skelter growth, investors say.
(Bloomberg) -- Activision Blizzard Inc. Chief Executive Officer Bobby Kotick responded to the threat of an employee walkout with an all-staff email Tuesday, apologizing and calling the company’s recent actions “tone deaf.”Employees at Activision Blizzard called for the walkout on Wednesday to protest the company’s responses to a recent sexual discrimination lawsuit and demanding more equitable treatment for underrepresented staff.In Kotick’s message, the CEO said the company had hired law firm W
In this article, we will be looking at the 10 best dividend aristocrats with over 4% yield. If you want to skip our detailed analysis of dividend investing, you can go directly to the 5 Best Dividend Aristocrats with Over 4% Yield. According to data from a book called Active Value Investing: Making Money in […]
When a stock’s price falls into the doldrums, it’s tempting to just avoid those shares. After all, rock bottom prices usually happen for a reason, and those reasons are usually not good for the stock’s prospects. But there are times – more frequent than most would guess – that this common wisdom runs counter to the facts. Because the fact is, many fundamentally sound stocks can and do see periods of falling share price. Maybe there was change in company leadership, or a hyped product failed to m
Penny stocks are a study in contrasts. They’re equities whose share price stands below $5, and that low price opens up a wide field of possibilities. Chief among these are the ultra-low cost of entry, combined with triple-digit upside potentials. These are stocks that truly can jump sky-high when conditions are right. But penny investors had better be risk tolerant, because these stocks also offer a range of possible downsides. First, there’s that ultra-low cost of entry; it raises the question,
This might not be the reaction you were expecting to today's news from Wall Street, where investment bank Daiwa downgraded shares of both New Oriental Education and TAL Education to "hold" today and Deutsche Bank did the same to New Oriental, TAL, and Gaotu Techedu. As Deutsche explains in a note covered by TheFly.com, the Chinese State Council has just published its "Opinions on Further Alleviating the Burden of Homework and After-School Tutoring for Students in Compulsory Education," and the news is actually even worse than feared.
For at least a decade now, value investors have had a terrible time, and the resurgence of value stocks in the U.S. this year has been pretty mild.
Apple beat analyst expectations for its Q3 earnings thanks to the performance of its iPhone 12.
(Bloomberg) -- Oil rose in New York after an industry report pointed to a decline in U.S. fuel and crude stockpiles, while the dollar erased gains.West Texas Intermediate futures added 1.2% to trade above $72 a barrel after slipping for a second session on Tuesday. The American Petroleum Institute reported a 6.23 million-barrel weekly drop in gasoline inventories, according to people familiar with the figures. That would be the biggest draw in motor fuel stockpiles since March if confirmed by go
The software giant's revenue rose 21% in its latest quarter, which was more than analysts expected. The company sees continued strong growth ahead.